Enzyme Inhibitors Market - Forecast(2019 - 2024)

Report Code: HCR 0289 Report Format: PDF + Excel (Delivery in 48 Hrs)
Enzyme Inhibitors is a molecule which acts by binding to an enzyme reversibly or irreversibly and decreasing or completely inhibiting its catalytic activity. Enzyme inhibitors are made up of protein and they occur naturally. Since blocking an enzyme's activity alter a biochemical process and cause imbalance which may terminate and/or slow down a process. Enzymes are involved in metabolism they regulate various metabolic pathways. In insects and some animals natural enzyme inhibitors are produced and are used as defense system against predators. Majority of drugs to treat a number of chronic and/or life-threatening diseases are developed with a mechanism of action directed towards enzyme inhibition. Enzyme specificity and potency are the important factors considered while developing a drug. A high specificity and potency ensures that a drug will have few side effects and strong therapeutic effect. Also, enzyme inhibitors are used as diagnostic agent to screen various diseases.

Factors driving global demand for Enzyme Inhibitors are its wide applications in pharmaceutical, agrochemical industries. Restraining factors for enzyme inhibitor market is patent expiry of various drugs.

This report provides information on enzyme inhibitors market size for the year 2014-2016, and forecast of the same for year 2021. It also focuses on market drivers, challenges, restraints, market dynamics, growth indicators, competitive landscape, potential growth opportunities and other key aspects with respect to enzyme inhibitors market.
 
Enzyme Inhibitors Market

The market for enzyme inhibitors is expanding with the rising incidence of enzyme based diseases and increasing research and development activities. In developed countries like US, Europe the market growth for enzyme inhibitor is high because of better diagnosis rate for the diseases, availability of medical facility, infrastructure, awareness and available treatment options. In Asia pacific region Japan, china and India are most potential markets due to economic development, improvement in medical facilities and growing population.

This report identifies global enzyme inhibitor market on the basis of application and regional market as follows:
  • Enzyme inhibitor market is segmented based on application. In drug development, as a diagnostic agent and to synthesize pesticides
  • This report is further segmented based on potential markets for enzyme inhibitors. A detailed analysis by region – North America, Europe, Asia Pacific (APAC) and Rest of the World (RoW), has been provided in this report
Sample Companies Profiled in this Report are:
  • Ranbaxy Laboratories Ltd
  • AstraZeneca
  • Merck
  • Pfizer 
  • Roche
  • 10+
1. Enzyme Inhibitors – Market Overview
2. Executive Summary
3. Enzyme Inhibitors Market - Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Enzyme Inhibitors Market- Market Forces
   4.1. Drivers
      4.1.1. Increased focus on R&D
   4.2. Restraints
      4.2.1. Patent expiry of major drugs
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Force Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Customers 
      4.5.3. Threat of New Entrants 
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Enzyme Inhibitors Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis 
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Enzyme Inhibitors Market, By application
   6.1. Pharmaceutical Industry
   6.2. Agrochemical Industry
7. Enzyme Inhibitors Market, By Geography
   7.1. Introduction
   7.2. North America
      7.2.1. US
      7.2.2. Canada
      7.2.3. Mexico
   7.3. Europe
      7.3.1. U.K.
      7.3.2. France
      7.3.3. Germany
      7.3.4. Italy
      7.3.5. Spain
      7.3.6. Rest of Europe
   7.4. Asia Pacific
      7.4.1. China
      7.4.2. South Korea
      7.4.3. Japan
      7.4.4. India
      7.4.5. Rest of Asia Pacific
   7.5. RoW
8. Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply - Contract
9. Company Profiles (Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)
   9.1. Roche
   9.2. Ranbaxy Laboratories Ltd
   9.3. Merck KGaA
   9.4. Pfizer
   9.5. Novartis
   9.6. Takeda Pharma
   9.7. AstraZeneca
   9.8. Johnson & Johnson
   9.9. Eli Lilly
   9.10. Amgen
*More than 10 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix
   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Expert Insights
List of Tables:

Table 1: Enzyme Inhibitors Market Overview 2019-2024
Table 2: Enzyme Inhibitors Market Leader Analysis 2018-2019 (US$)
Table 3: Enzyme Inhibitors Market Product Analysis 2018-2019 (US$)
Table 4: Enzyme Inhibitors Market End User Analysis 2018-2019 (US$)
Table 5: Enzyme Inhibitors Market Patent Analysis 2013-2018* (US$)
Table 6: Enzyme Inhibitors Market Financial Analysis 2018-2019 (US$)
Table 7: Enzyme Inhibitors Market Driver Analysis 2018-2019 (US$)
Table 8: Enzyme Inhibitors Market Challenges Analysis 2018-2019 (US$)
Table 9: Enzyme Inhibitors Market Constraint Analysis 2018-2019 (US$)
Table 10: Enzyme Inhibitors Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Enzyme Inhibitors Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Enzyme Inhibitors Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Enzyme Inhibitors Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Enzyme Inhibitors Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Enzyme Inhibitors Market Value Chain Analysis 2018-2019 (US$)
Table 16: Enzyme Inhibitors Market Pricing Analysis 2019-2024 (US$)
Table 17: Enzyme Inhibitors Market Opportunities Analysis 2019-2024 (US$)
Table 18: Enzyme Inhibitors Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Enzyme Inhibitors Market Supplier Analysis 2018-2019 (US$)
Table 20: Enzyme Inhibitors Market Distributor Analysis 2018-2019 (US$)
Table 21: Enzyme Inhibitors Market Trend Analysis 2018-2019 (US$)
Table 22: Enzyme Inhibitors Market Size 2018 (US$)
Table 23: Enzyme Inhibitors Market Forecast Analysis 2019-2024 (US$)
Table 24: Enzyme Inhibitors Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Enzyme Inhibitors Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 26: Enzyme Inhibitors Market By Application, Revenue & Volume, By Pharmaceutical Industry, 2019-2024 ($)
Table 27: Enzyme Inhibitors Market By Application, Revenue & Volume, By Agrochemical Industry, 2019-2024 ($)
Table 28: North America Enzyme Inhibitors Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 29: South america Enzyme Inhibitors Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 30: Europe Enzyme Inhibitors Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 31: APAC Enzyme Inhibitors Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 32: Middle East & Africa Enzyme Inhibitors Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 33: Russia Enzyme Inhibitors Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 34: Israel Enzyme Inhibitors Market, Revenue & Volume, By Application, 2019-2024 ($)
Table 35: Top Companies 2018 (US$)Enzyme Inhibitors Market, Revenue & Volume
Table 36: Product Launch 2018-2019Enzyme Inhibitors Market, Revenue & Volume
Table 37: Mergers & Acquistions 2018-2019Enzyme Inhibitors Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Enzyme Inhibitors Market 2019-2024
Figure 2: Market Share Analysis for Enzyme Inhibitors Market 2018 (US$)
Figure 3: Product Comparison in Enzyme Inhibitors Market 2018-2019 (US$)
Figure 4: End User Profile for Enzyme Inhibitors Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Enzyme Inhibitors Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Enzyme Inhibitors Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Enzyme Inhibitors Market 2018-2019
Figure 8: Ecosystem Analysis in Enzyme Inhibitors Market 2018
Figure 9: Average Selling Price in Enzyme Inhibitors Market 2019-2024
Figure 10: Top Opportunites in Enzyme Inhibitors Market 2018-2019
Figure 11: Market Life Cycle Analysis in Enzyme Inhibitors Market
Figure 12: GlobalBy ApplicationEnzyme Inhibitors Market Revenue, 2019-2024 ($)
Figure 13: Global Enzyme Inhibitors Market - By Geography
Figure 14: Global Enzyme Inhibitors Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 15: Global Enzyme Inhibitors Market CAGR, By Geography, 2019-2024 (%)
Figure 16: North America Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 17: US Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 18: US GDP and Population, 2018-2019 ($)
Figure 19: US GDP – Composition of 2018, By Sector of Origin
Figure 20: US Export and Import Value & Volume, 2018-2019 ($)
Figure 21: Canada Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 22: Canada GDP and Population, 2018-2019 ($)
Figure 23: Canada GDP – Composition of 2018, By Sector of Origin
Figure 24: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 25: Mexico Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 26: Mexico GDP and Population, 2018-2019 ($)
Figure 27: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 28: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 29: South America Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 30: Brazil Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 31: Brazil GDP and Population, 2018-2019 ($)
Figure 32: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 33: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 34: Venezuela Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 35: Venezuela GDP and Population, 2018-2019 ($)
Figure 36: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 37: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 38: Argentina Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 39: Argentina GDP and Population, 2018-2019 ($)
Figure 40: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 41: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 42: Ecuador Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 43: Ecuador GDP and Population, 2018-2019 ($)
Figure 44: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 45: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 46: Peru Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 47: Peru GDP and Population, 2018-2019 ($)
Figure 48: Peru GDP – Composition of 2018, By Sector of Origin
Figure 49: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 50: Colombia Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 51: Colombia GDP and Population, 2018-2019 ($)
Figure 52: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 53: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 54: Costa Rica Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 55: Costa Rica GDP and Population, 2018-2019 ($)
Figure 56: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 57: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 58: Europe Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 59: U.K Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 60: U.K GDP and Population, 2018-2019 ($)
Figure 61: U.K GDP – Composition of 2018, By Sector of Origin
Figure 62: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 63: Germany Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 64: Germany GDP and Population, 2018-2019 ($)
Figure 65: Germany GDP – Composition of 2018, By Sector of Origin
Figure 66: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 67: Italy Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 68: Italy GDP and Population, 2018-2019 ($)
Figure 69: Italy GDP – Composition of 2018, By Sector of Origin
Figure 70: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 71: France Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 72: France GDP and Population, 2018-2019 ($)
Figure 73: France GDP – Composition of 2018, By Sector of Origin
Figure 74: France Export and Import Value & Volume, 2018-2019 ($)
Figure 75: Netherlands Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 76: Netherlands GDP and Population, 2018-2019 ($)
Figure 77: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 78: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 79: Belgium Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 80: Belgium GDP and Population, 2018-2019 ($)
Figure 81: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 82: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 83: Spain Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 84: Spain GDP and Population, 2018-2019 ($)
Figure 85: Spain GDP – Composition of 2018, By Sector of Origin
Figure 86: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 87: Denmark Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 88: Denmark GDP and Population, 2018-2019 ($)
Figure 89: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 90: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 91: APAC Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 92: China Enzyme Inhibitors Market Value & Volume, 2019-2024
Figure 93: China GDP and Population, 2018-2019 ($)
Figure 94: China GDP – Composition of 2018, By Sector of Origin
Figure 95: China Export and Import Value & Volume, 2018-2019 ($)Enzyme Inhibitors Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 96: Australia Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 97: Australia GDP and Population, 2018-2019 ($)
Figure 98: Australia GDP – Composition of 2018, By Sector of Origin
Figure 99: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 100: South Korea Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 101: South Korea GDP and Population, 2018-2019 ($)
Figure 102: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 103: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 104: India Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 105: India GDP and Population, 2018-2019 ($)
Figure 106: India GDP – Composition of 2018, By Sector of Origin
Figure 107: India Export and Import Value & Volume, 2018-2019 ($)
Figure 108: Taiwan Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 109: Taiwan GDP and Population, 2018-2019 ($)
Figure 110: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 111: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 112: Malaysia Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 113: Malaysia GDP and Population, 2018-2019 ($)
Figure 114: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 115: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 116: Hong Kong Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 117: Hong Kong GDP and Population, 2018-2019 ($)
Figure 118: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 119: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 120: Middle East & Africa Enzyme Inhibitors Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 121: Russia Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 122: Russia GDP and Population, 2018-2019 ($)
Figure 123: Russia GDP – Composition of 2018, By Sector of Origin
Figure 124: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 125: Israel Enzyme Inhibitors Market Value & Volume, 2019-2024 ($)
Figure 126: Israel GDP and Population, 2018-2019 ($)
Figure 127: Israel GDP – Composition of 2018, By Sector of Origin
Figure 128: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 129: Entropy Share, By Strategies, 2018-2019* (%)Enzyme Inhibitors Market
Figure 130: Developments, 2018-2019*Enzyme Inhibitors Market
Figure 131: Company 1 Enzyme Inhibitors Market Net Revenue, By Years, 2018-2019* ($)
Figure 132: Company 1 Enzyme Inhibitors Market Net Revenue Share, By Business segments, 2018 (%)
Figure 133: Company 1 Enzyme Inhibitors Market Net Sales Share, By Geography, 2018 (%)
Figure 134: Company 2 Enzyme Inhibitors Market Net Revenue, By Years, 2018-2019* ($)
Figure 135: Company 2 Enzyme Inhibitors Market Net Revenue Share, By Business segments, 2018 (%)
Figure 136: Company 2 Enzyme Inhibitors Market Net Sales Share, By Geography, 2018 (%)
Figure 137: Company 3 Enzyme Inhibitors Market Net Revenue, By Years, 2018-2019* ($)
Figure 138: Company 3 Enzyme Inhibitors Market Net Revenue Share, By Business segments, 2018 (%)
Figure 139: Company 3 Enzyme Inhibitors Market Net Sales Share, By Geography, 2018 (%)
Figure 140: Company 4 Enzyme Inhibitors Market Net Revenue, By Years, 2018-2019* ($)
Figure 141: Company 4 Enzyme Inhibitors Market Net Revenue Share, By Business segments, 2018 (%)
Figure 142: Company 4 Enzyme Inhibitors Market Net Sales Share, By Geography, 2018 (%)
Figure 143: Company 5 Enzyme Inhibitors Market Net Revenue, By Years, 2018-2019* ($)
Figure 144: Company 5 Enzyme Inhibitors Market Net Revenue Share, By Business segments, 2018 (%)
Figure 145: Company 5 Enzyme Inhibitors Market Net Sales Share, By Geography, 2018 (%)
Figure 146: Company 6 Enzyme Inhibitors Market Net Revenue, By Years, 2018-2019* ($)
Figure 147: Company 6 Enzyme Inhibitors Market Net Revenue Share, By Business segments, 2018 (%)
Figure 148: Company 6 Enzyme Inhibitors Market Net Sales Share, By Geography, 2018 (%)
Figure 149: Company 7 Enzyme Inhibitors Market Net Revenue, By Years, 2018-2019* ($)
Figure 150: Company 7 Enzyme Inhibitors Market Net Revenue Share, By Business segments, 2018 (%)
Figure 151: Company 7 Enzyme Inhibitors Market Net Sales Share, By Geography, 2018 (%)
Figure 152: Company 8 Enzyme Inhibitors Market Net Revenue, By Years, 2018-2019* ($)
Figure 153: Company 8 Enzyme Inhibitors Market Net Revenue Share, By Business segments, 2018 (%)
Figure 154: Company 8 Enzyme Inhibitors Market Net Sales Share, By Geography, 2018 (%)
Figure 155: Company 9 Enzyme Inhibitors Market Net Revenue, By Years, 2018-2019* ($)
Figure 156: Company 9 Enzyme Inhibitors Market Net Revenue Share, By Business segments, 2018 (%)
Figure 157: Company 9 Enzyme Inhibitors Market Net Sales Share, By Geography, 2018 (%)
Figure 158: Company 10 Enzyme Inhibitors Market Net Revenue, By Years, 2018-2019* ($)
Figure 159: Company 10 Enzyme Inhibitors Market Net Revenue Share, By Business segments, 2018 (%)
Figure 160: Company 10 Enzyme Inhibitors Market Net Sales Share, By Geography, 2018 (%)
Figure 161: Company 11 Enzyme Inhibitors Market Net Revenue, By Years, 2018-2019* ($)
Figure 162: Company 11 Enzyme Inhibitors Market Net Revenue Share, By Business segments, 2018 (%)
Figure 163: Company 11 Enzyme Inhibitors Market Net Sales Share, By Geography, 2018 (%)
Figure 164: Company 12 Enzyme Inhibitors Market Net Revenue, By Years, 2018-2019* ($)
Figure 165: Company 12 Enzyme Inhibitors Market Net Revenue Share, By Business segments, 2018 (%)
Figure 166: Company 12 Enzyme Inhibitors Market Net Sales Share, By Geography, 2018 (%)
Figure 167: Company 13 Enzyme Inhibitors Market Net Revenue, By Years, 2018-2019* ($)
Figure 168: Company 13 Enzyme Inhibitors Market Net Revenue Share, By Business segments, 2018 (%)
Figure 169: Company 13 Enzyme Inhibitors Market Net Sales Share, By Geography, 2018 (%)
Figure 170: Company 14 Enzyme Inhibitors Market Net Revenue, By Years, 2018-2019* ($)
Figure 171: Company 14 Enzyme Inhibitors Market Net Revenue Share, By Business segments, 2018 (%)
Figure 172: Company 14 Enzyme Inhibitors Market Net Sales Share, By Geography, 2018 (%)
Figure 173: Company 15 Enzyme Inhibitors Market Net Revenue, By Years, 2018-2019* ($)
Figure 174: Company 15 Enzyme Inhibitors Market Net Revenue Share, By Business segments, 2018 (%)
Figure 175: Company 15 Enzyme Inhibitors Market Net Sales Share, By Geography, 2018 (%)